文献速递痛风与晶体性关节病

聚类定义的痛风亚型呈现不同的慢性肾病轨迹:中国前瞻性队列的机器学习研究

Cluster-defined gout subtypes exhibit divergent chronic kidney disease trajectories: a machine learning approach in a Chinese prospective cohort.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

该前瞻性队列纳入1497例中国痛风患者,基于血尿酸、尿酸排泄分数、痛风病程和肾结石负荷进行K-means聚类,识别出5个临床亚型。中位随访期间153例(10.22%)进展至CKD≥3期,其中低排泄高尿酸型(Cluster 4)和肾结石型(Cluster 5)的CKD进展风险显著升高,遗传风险评分进一步放大Cluster 4的肾脏风险。

要点

  • 聚类分析识别出5个痛风亚型,其中低排泄高尿酸型和肾结石型CKD进展风险最高。
  • 达到目标血尿酸水平和减少肾结石负荷与较低的CKD进展风险独立相关。
  • 遗传风险评分可进一步放大低排泄高尿酸型患者的肾脏风险。

核心结论

  • 基于K-means聚类的痛风分型可识别具有不同CKD轨迹的亚组,结合临床表型和遗传分析可能改善个体化风险分层。

研究设计与样本

  • 前瞻性队列研究,纳入1497例中国痛风患者,随访CKD进展,采用K-means聚类分析四个核心临床变量。

主要发现

  • 随访4166人年期间,153例参与者(10.22%)进展至CKD≥3期。
  • Cluster 4(低排泄、高尿酸)和Cluster 5(肾结石)与CKD进展风险增加显著相关,调整后风险比分别为2.19(95%CI 1.20-4.01)和3.52(95%CI 1.91-6.48)。
  • 遗传风险评分进一步放大了Cluster 4的肾脏风险。
  • 达到目标血尿酸水平和减少肾结石负荷与较低的CKD进展风险独立相关。

关键数值与推荐

  • 聚类基于四个核心临床变量:血尿酸、尿酸排泄分数(区分高排泄和低排泄)、痛风病程和肾结石负荷。
  • 主要结局为CKD≥3期的发生率,采用Cox比例风险模型评估。
  • 遗传风险采用基于20个与痛风和 Hyperuricemia 相关的单核苷酸多态性构建的未加权遗传风险评分评估。

临床怎么用

  • 对痛风患者可依据血尿酸、尿酸排泄分数、病程和肾结石负荷进行亚型划分,识别CKD进展高风险人群。
  • 对低排泄高尿酸型和肾结石型患者应加强肾功能监测和针对性预防。
  • 达到目标血尿酸水平和减少肾结石负荷可能有助于降低CKD进展风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To systematically evaluate the contribution of clinical heterogeneity to chronic kidney disease (CKD) progression in gout patients using data-driven phenotyping, and to assess whether incorporating genetic risk improves prediction of renal outcomes. METHODS: In this prospective cohort study, 1497 Chinese gout patients were enrolled and followed for CKD progression. K-means clustering was applied to four core clinical variables: serum urate (SU), fractional excretion of uric acid (FEUA) (i.e. high- and low-excretion), gout duration and kidney stone burden. The primary outcome was the incidence of CKD stage ≥3, assessed using Cox proportional hazards models. Genetic risk was evaluated using an unweighted genetic risk score derived from 20 single nucleotide polymorphisms associated with gout and hyperuricaemia. RESULTS: Over a follow-up of 4166 person-years, 153 participants (10.22%) developed CKD stage ≥3. Five clinical clusters were identified: Cluster 1 (high-excretion, low-urate), Cluster 2 (low-excretion, low-urate), Cluster 3 (long-duration), Cluster 4 (low-excretion, high-urate) and Cluster 5 (nephrolithiasis). Cluster 4 and Cluster 5 were significantly associated with increased risk of CKD progression, with adjusted hazard ratios of 2.19 (95% CI 1.20-4.01) and 3.52 (95% CI 1.91-6.48), respectively. Genetic predisposition, via risk score, further amplified renal risk in Cluster 4. Achieving target SU levels and reductions in kidney stone burden were independently associated with a lower risk of CKD progression. CONCLUSIONS: This study proposes a novel K-means clustering-based classification of gout, identifying subgroups with distinct CKD trajectories. Integration of clinical phenotyping and genetic profiling may enhance individualized risk stratification and guide targeted prevention strategies in gout-associated CKD.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Hu S, Cui L, Chen Y, et al. Cluster-defined gout subtypes exhibit divergent chronic kidney disease trajectories: a machine learning approach in a Chinese prospective cohort. Rheumatology (Oxford). 2026. PMID: 41934097. doi:10.1093/rheumatology/keag158

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。